Selenium is a trace element that is considered to be essential both in animals and humans. Selenium deficiency has been linked to a multitude of conditions such as Kashin cardiomyopathy, Kashin-Beck osteoartropathy, systemic immune response syndrome and sepsis in adults, and chronic lung disease and hemolytic anemia in preterm infants. [1] [2] [3] [4] [5] [6] [7] Selenium as selenocysteine is a component of the metalloenzymes that are present in many body tissues, including glutathione peroxidase (GSHPx) and iodothyronine deiodinase type I. [7] [8] [9] GSHPx serves as an antioxidant, which protects cells from free radical damage. Deficient GSHPx activity may be a major contributor to the organ damage seen in disorders such as Kashin cardiomyopathy and chronic lung disease of preterm infants. The second enzyme, iodothyronine deiodinase type I is dependent on selenium, suggesting that selenium deficiency might lead to abnormalities in thyroid hormone metabolism. If premature infants are at risk for selenium deficiency, this in turn might lead to abnormal thyroid hormone metabolism in this population.
Much of the information regarding selenium deficiency and supplementation in newborn infants has been extrapolated from adult data. In the term infant, cord plasma selenium levels have been shown to be roughly half those of adult values. 10, 11 Inadequate selenium stores due to decreased gestational age and an extended period of rapid growth contribute to an increased risk of selenium deficiency in the preterm infant. [12] [13] [14] In extremely low birth weight (ELBW) infants, respiratory distress syndrome and other conditions that cause increased nutritional requirements compound these problems. Current guidelines for selenium supplementation are 2 g/kg per day in the preterm population, 12 but these recommendations may be inadequate.
Our study aims were to evaluate whether supplementation with 2 g/kg per day of selenium by parenteral nutrition (PN) maintains selenium plasma levels in ELBW infants, and whether hypothyroidism is related to selenium deficiency in these infants.
MATERIALS AND METHODS Subjects
Schneider Children's Medical Center houses a regional neonatal intensive care unit with 500 infants admitted annually. Infants admitted over a 1-year period starting in July of 1997 whose birth weight was Յ1000 gm and who received more than two-thirds of their calories parenterally were eligible for this study. Exclusion criteria were known genetic, metabolic, or endocrine disorders, and sepsis. All
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infants participating in the study were treated according to the standard protocols of the neonatal unit.
Study Design
Preterm infants consecutively admitted to the neonatal unit were evaluated at day 10 of life for selenium deficiency and for hypothyroidism. Parental consent was obtained before enrollment. The study received the approval of the local ethics committee. All information about neonatal course, PN, and enteral nutrition was collected prospectively. Information regarding neonatal course included episodes of sepsis, ventilatory and oxygen requirements, mortality, and thyroid function at discharge.
Nutritional Practices
PN is routinely started on day 3 of life in all infants who are not being fed enterally in sufficient amounts. Carbohydrates are given as a 5% dextrose solution and progressively increased as tolerated. Initially, 0.5 to 1.0 gm/kg per day of amino acids (Vaminolact, Kabi Pharmacia Inc., Stockholm, Sweden) is started, and similar amounts of a 20% lipid solution are provided (Intralipid, Kabi Pharmacia Inc.). The amino acids and lipids are progressively increased to 3 gm/kg per day as tolerated. Vitamins (MVI-Pediatric, Astra Pharmaceutical products, Westborough, MA) and trace elements (Lyphomed, Rosemont, IL) are supplemented according to established guidelines. 15 Full trace element supplementation is initiated on day 3 of life. The amount of selenium supplemented is 2 g/kg per day provided as selenious acid (Selepen Fujisawa Inc., Deerfield, IL). Enteral feeding, preferably as expressed human milk, is started as early as possible, at 0.5 to 1 ml every 2 hours. If breastfeeding is not possible, premature formula (Enfalac, Mead Johnson Nutritionals, Evansville, IN) is substituted instead.
Blood Sampling
It is the routine practice of the neonatal unit to assess thyroid function (free T4, thyroid stimulating hormone (TSH)) on day 10 of life.
To minimize blood sampling, we chose to assess serum selenium levels on day 10 of life. As thyroid function was being assessed, 1 ml of blood was drawn for selenium analysis. Selenium samples were separated immediately, and the plasma fraction was stored at Ϫ20°C until analysis.
Laboratory Analysis
Selenium was determined by atomic spectrometry according to the method described by Thompson and Allen. 16 A GBC AVANTA atomic absorption spectrometer was used, equipped with a GBC System 3000 graphite furnace and PAL 3000 autosampler (GBC Scientific Equipment, Dandenong, Victoria, Australia). The serum samples were diluted 1/1 with 1% aqueous Triton X-100 (Sigma, St. Louis, MO); nickel nitrate (Sigma) was used as a matrix modifier. The instrument was calibrated using a commercial selenium standard solution (Sigma). The measurements were done in triplicates. The coefficient of variance was Ͻ10%.
Selenium deficiency was diagnosed when serum levels were Ͻ0.72 M. 17 Laboratory analysis of free T4 and TSH was performed using a commercially available immulite chemiluminescent enzyme immunoassay (DPC Diagnostic Products, Los Angeles, CA). Free T4 and TSH values were compared with normal values for gestational age. 18 For premature infants with a gestational age of 25 to 30 weeks, normal values of free T4 and TSH were 6.4 to 42.5 pM and 0.5 to 29 mU/l, respectively.
Statistical Analysis
Comparison between groups was done using the Student's t-test. Pearson correlation coefficients were calculated for the associations between serum selenium levels, free T4 serum levels, and TSH serum levels using SPSS software (SPSS for Windows 9.0; SPSS Inc., Chicago, IL). Significance was defined as p Յ 0.05.
RESULTS
A total of 40 infants were eligible for this study; parental consent was obtained for 33 infants, and data were available for analysis on 29 infants. The average gestational age of the infants was 26 Ϯ 1.7 weeks (mean Ϯ SD); average birth weight was 809 Ϯ 129 gm (mean Ϯ SD). Average ventilation requirement was 12.5 Ϯ 13.5 days (mean Ϯ SD). The infants were discharged at an average age of 85.8 Ϯ 25.6 days (mean Ϯ SD). Two of 29 infants died during the study period, giving a mortality rate of 6.8%. No episodes of sepsis were observed before evaluation of selenium and thyroid status.
The caloric intake of the infants was 51.4 Ϯ 17.2 kcal/kg per day (mean Ϯ SD), with 70% of the calories provided parenterally. Average parenteral protein and fat intakes were 1.8 Ϯ 0.6 and 1.3 Ϯ 0.6 gm/kg per day (mean Ϯ SD), respectively. Actual selenium intake was 1.82 Ϯ 0.48 g/kg per day (mean Ϯ SD, n ϭ 29).
Average plasma selenium was 0.54 Ϯ 0.13 M (mean Ϯ SD, n ϭ 29) on day 10 of life ( Figure 1) . A total of 26 of 29 infants had values lower than the minimum accepted for newborn infants. 17 The average free T4 serum level was 9.8 Ϯ 4.8 pM (mean Ϯ SD, n ϭ 29) (Figure 2) , and the average TSH serum level was 2.7 Ϯ 1.5 mU/l (mean Ϯ SD, n ϭ 29). Low free T4 was found in 10 of 26 infants with low selenium levels and in 0 of 3 infants with normal selenium levels. Elevated TSH was not found in any of the infants with low free T4.
All thyroid values were normal at discharge, establishing the transient nature of the hypothyroidism. We found no significant correlation between plasma selenium and free T4 (r ϭ 0.36, p ϭ 0.06), between plasma selenium and TSH (r ϭ 0.06, p ϭ 0.76), or between plasma selenium and gestational age (r ϭ 0.27, p ϭ 0.16). As expected, free T4 serum levels were significantly correlated with gestational age (r ϭ 0.45, p ϭ 0.02).
DISCUSSION
The main findings of our study are that serum selenium levels in ELBW infants are low despite adequate selenium supplementation according to current guidelines. Nevertheless, most infants had normal thyroid hormone levels, and no correlation was found between selenium serum levels and thyroid hormone levels.
Current recommendations for selenium supplementation are identical for preterm and fullterm infants. In the term infant, cord plasma selenium levels have been shown to be roughly half those of adult values. 10, 11 If adequate selenium is given in the neonatal period, plasma selenium would be expected to remain stable or slowly increase. However, in formula-fed infants, plasma selenium levels decline to Ͻ50% of cord levels by 4 to 10 weeks of age. 10, 19 When infants receive selenium supplementation to their formula, the decline in plasma selenium can be prevented and plasma selenium increases to close to adult values by 3 months of age, suggesting insufficient intake when selenium is not supplemented. 20 Selenium intake in fully breastfed infants averages 2.5 g/kg per day. 21 Increasing the daily selenium supplementation to this amount is physiological and has been shown to prevent a decline in plasma selenium in the premature population. 22 The selenium status of preterm infants can be improved by selenate fortification of their formulas in a similar fashion. 23 Premature infants are at an increased risk for selenium deficiency for a number of reasons, including limited selenium stores created during shortened gestation, a lengthened period of rapid growth, and possibly decreased selenium absorption in the early neonatal period. [12] [13] [14] It has been estimated that selenium retention in vitro is 1 g/kg per day, 14 and this must be taken into account when determining the optimal selenium supplementation in the preterm infant. The ELBW preterm population is at an even higher risk, because the previous risk factors are augmented with decreasing gestational age. The limited enteral intake (due to the risk of necrotizing enterocolitis), feeding intolerance, and slow increases in enteral feeding routinely practiced are common in the extremely premature population. As a result, this population relies mainly on PN to meet their nutritional needs. Lockitch et al. 24 demonstrated that selenium deficiency is a common problem in sick preterm infants weighing Ͻ1500 gm. It must be noted that generalizations about premature infants are inappropriate, as there are major differences in every weight group, with increasing demands as weight decreases. 25 We have used a serum selenium value of 0.72 M as a minimum normal value in preterm infants. This is based largely on a survey of serum selenium values in infants performed by Lockitch et al. 24 This survey also followed a subset of 16 premature infants, showing that serum selenium values continue to decrease during the first 4 weeks of life. Although Lockitch et al. 24 found lower serum selenium values in preterm infants, a previous study by Haga and Lunde 11 did not show any difference between preterm and fullterm values. It is not known how quickly adult serum selenium levels are obtained in the premature population. As normal serum selenium values for premature infants have not been well established, it is not possible to determine whether the low values found in this study represent true selenium deficiency.
Current guidelines for PN supplementation with selenium recommend adding 2 g/kg per day for preterm and fullterm infants alike. 15 No recommendation for an increased amount of selenium for the very immature preterm infant exists. Selenium supplementation of PN and formula with 1.68 g/kg per day in ELBW infants was found to be inadequate to prevent plasma selenium levels from decreasing. 26 In preterm infants with a mean birth weight of 1129 gm, Daniels et al. 22 showed that use of an increased selenium supplementation of 2 to 2.5 g/kg per day prevented decline in plasma selenium levels.
The actual intake of selenium can fall short of the expected intake due to temporary use of fluids other than PN or due to grading from PN to enteral feeding. Daniels et al. 22 aimed for an intake of 3 g/kg per day but achieved only 2 to 2.5 g/kg per day. Our actual selenium intake was 1.82 g/kg per day, marginally lower than the recommended 2 g/kg per day. Although the deviation is minimal, it represents the difficulty in achieving optimal supplementation in the ELBW infant. The low selenium serum levels support the need to provide more selenium with PN to achieve adequate intake.
A number of indexes for the evaluation of selenium status exist. These include evaluation of selenium in whole blood, plasma, erythrocytes, urine, or hair. 27 GSHPx is considered a reliable index in adults. 27 We elected not to measure GSHPx because it has been found to be a poor index in premature infants, 28 with low correlation with selenium levels. 19, 29 We chose to use serum selenium because we desired a reliable selenium index that responds relatively quickly to nutritional supplementation. 29, 30 Selenium has been linked to abnormal thyroid hormone metabolism by animal studies, 31, 32 by epidemiological data, 1,2,7 and by clinical studies in humans. 4, 33 Selenium deficiency has also been linked to euthyroid sick syndrome, 33 which might have a similar etiology to the transient hypothyroidism frequently seen in extremely premature infants. 34 Darlow et al. 20 failed to show any correlation between selenium and T3, T4, or TSH. This study was done in fullterm infants. We postulated that low selenium levels would be found in ELBW infants with hypothyroidism, providing another argument for selenium supplementation. The finding of normal thyroid markers in ELBW infants with selenium deficiency and the lack of correlation between thyroid hormone abnormality and serum selenium levels indicate that selenium does not have a major role in neonatal hypothyroidism. Due to the small sample size and the multiple factors that can cause either low selenium levels or hypothyroidism, we cannot definitely conclude that there is no relationship between thyroid status and low selenium levels. In addition, because T3 is not measured routinely in our unit and the ethical committee did not approve additional blood sampling, we could not determine whether selenium deficiency had any influence on the peripheral conversion of T4 to T3 in ELBW infants.
In conclusion, our findings suggest that the recommended selenium supplementation in the ELBW population is inadequate to achieve a normal serum selenium level and should be increased. In addition, our study did not demonstrate that selenium deficiency induces hypothyroidism.
